Biosytes, Inc. was awarded United States Patent 6,056,971 for the Bio-Solv process used to enhance the bioavailability and absorption of Coenzyme Q10. Tishcon Corporation, Westbury, NY has the exclusive worldwide rights to the patented process. The Bio-Solv process is used in Tishcon’s Q-Gel Coenzyme Q10 formulas. It improves absorption by making CoQ10 virtually water soluble […]
Read MoreWESTBURY, N.Y., April 19 / PRNewswire / — Tishcon Corp. announced that the U.S. FDA has granted the firm Orphan Drug Designations for UBIQUINOL (Coenzyme Q10) in the treatment of Pediatric Congestive Heart Failure and Huntington’s Disease.
Read MoreTishcon’s Hydro Q Sorb 20% CoQ10 powder obtains certification from Consumer Labs (CL) Read More
Read MoreThis study is sponsored by the FDA Orphan Products Division, Tishcon Corp., & General Clinical Research Centers funded by the National Institutes of Health. Study Information The study will help provide information to determine if Coenzyme Q10 (CoQ10) is a safe and effective treatment for children with mitochondrial diseases. There are no cures for mitochondrial […]
Read MoreThe American College of Nutrition (ACN) honored Raj K. Chopra as the 2006 Industry Recipient of the prestigious Bieber Award “in recognition of his outstanding academic accomplishments and distinguished contributions in the nutrition industry”. The 47th Annual ACN President’s Dinner and Awards Presentation was held on Saturday, October 7th, 2006 at the Grand Sierra Resort […]
Read More